HEMPALTA to Deliver Breakthrough Investor Presentation at New York Venture Summit
Share
NEW YORK CITY – HEMPALTA recently became one of only 200 companies worldwide to earn a coveted presentation slot at the 21st annual New York Venture Summit this week. The New York City-based event connects founders of the hottest venture backed, emerging, and early-stage companies with an exclusive audience of venture capitalists, corporate investors, private investors, investment bankers, and strategic partners.
The New York Venture Summit, presented by youngStartup Ventures, is the premier industry gathering for promising companies in tech, AI, fintech, cleantech, medtech, life sciences, and healthcare fields. With thousands of attendees each year and over 150 featured investors with over $250B under management, the New York Venture Summit is the event where significant deals are made. For HEMPALTA, it is a rare opportunity to connect with investors, share our vision, and secure the funding we need to continue our important work.
“We’re excited to be one of the few companies selected to present at the New York Venture Summit,” said Darren Bondar, CEO of HEMPALTA. “This is a unique chance for us to connect with top investors and share our vision for a more sustainable future through hemp innovation. We’re looking forward to bringing our mission to a global stage.”
